David Alexandre "Da" Gros
About David Alexandre "Da" Gros
David-Alexandre C. Gros is the Chief Executive Officer and co-founder of Imbria Pharmaceuticals Inc. He has held various leadership roles in the pharmaceutical and healthcare industries, including positions at Neurocrine Biosciences, Alnylam Pharmaceuticals, and Sanofi.
David-Alexandre C. Gros: Chief Executive Officer
David-Alexandre C. Gros is a highly experienced executive in the pharmaceutical and healthcare sectors. He currently serves as the Chief Executive Officer and Chairman of the Board of Directors at Imbria Pharmaceuticals Inc., a company he co-founded. His leadership at Imbria Pharmaceuticals is marked by a focus on advancing innovative treatments aimed at improving patient outcomes.
David-Alexandre C. Gros' Education and Expertise
David-Alexandre C. Gros holds an impressive academic background. He earned a Doctor of Medicine (M.D.) from The Johns Hopkins University School of Medicine, one of the top medical schools in the United States. He also holds a Master of Business Administration (M.B.A.) from Harvard Business School, complementing his medical expertise with business acumen. Additionally, he received his Bachelor of Arts (B.A.) from Dartmouth College.
David-Alexandre C. Gros' Background in Pharmaceuticals and Biotechnology
David-Alexandre C. Gros has held numerous leadership roles in the pharmaceutical and biotechnology industries. Prior to his current role, he served as President and Chief Operating Officer of Neurocrine Biosciences, Inc. He was also the Chief Business and Principal Financial Officer at Alnylam Pharmaceuticals, Inc. Moreover, he worked as Chief Strategy Officer at Sanofi, S.A., further broadening his expertise in global healthcare strategy.
David-Alexandre C. Gros' Experience in Investment Banking and Consulting
In addition to his roles in the pharmaceutical and biotechnology industries, David-Alexandre C. Gros has significant experience in investment banking and consulting. He held leadership positions in healthcare investment banking at Centerview Partners, LLC, and Merrill Lynch, Pierce, Fenner & Smith Inc. He also worked in healthcare consulting at McKinsey & Company, adding a financial and strategic dimension to his professional skill set.
David-Alexandre C. Gros' Board Memberships and Co-Founding Ventures
David-Alexandre C. Gros has a notable record of co-founding and serving on the boards of several healthcare and pharmaceutical companies. He co-founded Imbria Pharmaceuticals Inc. and Eliem Therapeutics, Inc., demonstrating his entrepreneurial spirit and commitment to innovation. Additionally, he has served on the Board of Directors of Eliem Therapeutics, Inc., and Saint Jean Groupe, S.A., underlining his leadership and governance experience in the industry.